Evidence map›Paper›PMID 33800016›Full record

ArticleInternational journal of molecular sciences2021

Lung Surfactant Decreases Biochemical Alterations and Oxidative Stress Induced by a Sub-Toxic Concentration of Carbon Nanoparticles in Alveolar Epithelial and Microglial Cells.

Giuseppe Caruso, Claudia G Fresta, Angelita Costantino, Giacomo Lazzarino, Angela M Amorini, Giuseppe Lazzarino, Barbara Tavazzi, Susan M Lunte, Prajnaparamita Dhar, Massimo Gulisano and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Giuseppe CarusoDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0003-1571-5327
Claudia G FrestaDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.
Angelita CostantinoDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.
Giacomo LazzarinoUniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.ORCID 0000-0003-1639-0966
Angela M AmoriniDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.ORCID 0000-0003-3525-9955
Giuseppe LazzarinoDepartment of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95125 Catania, Italy.ORCID 0000-0002-5917-7279
Barbara TavazziDepartment of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of the Sacred Heart of Rome, 00168 Rome, Italy.ORCID 0000-0001-8743-0895
Susan M LunteRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS 66047-1620, USA.
Prajnaparamita DharDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047-1620, USA.ORCID 0000-0002-5821-5253
Massimo GulisanoDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0001-8654-1745
Filippo CaraciDepartment of Drug and Health Sciences, University of Catania, 95125 Catania, Italy.ORCID 0000-0002-9867-6054
University of Catania · ITUniversity of Kansas · USUniversità Cattolica del Sacro Cuore · IT

Funding

NIH HHS COBRE P20GM103638
6 · The paper itself

Abstract

Carbon-based nanomaterials are nowadays attracting lots of attention, in particular in the biomedical field, where they find a wide spectrum of applications, including, just to name a few, the drug delivery to specific tumor cells and the improvement of non-invasive imaging methods. Nanoparticles inhaled during breathing accumulate in the lung alveoli, where they interact and are covered with lung surfactants. We recently demonstrated that an apparently non-toxic concentration of engineered carbon nanodiamonds (ECNs) is able to induce oxidative/nitrosative stress, imbalance of energy metabolism, and mitochondrial dysfunction in microglial and alveolar basal epithelial cells. Therefore, the complete understanding of their "real" biosafety, along with their possible combination with other molecules mimicking the in vivo milieu, possibly allowing the modulation of their side effects becomes of utmost importance. Based on the above, the focus of the present work was to investigate whether the cellular alterations induced by an apparently non-toxic concentration of ECNs could be counteracted by their incorporation into a synthetic lung surfactant (DPPC:POPG in 7:3 molar ratio). By using two different cell lines (alveolar (A549) and microglial (BV-2)), we were able to show that the presence of lung surfactant decreased the production of ECNs-induced nitric oxide, total reactive oxygen species, and malondialdehyde, as well as counteracted reduced glutathione depletion (A549 cells only), ameliorated cell energy status (ATP and total pool of nicotinic coenzymes), and improved mitochondrial phosphorylating capacity. Overall, our results on alveolar basal epithelial and microglial cell lines clearly depict the benefits coming from the incorporation of carbon nanoparticles into a lung surfactant (mimicking its in vivo lipid composition), creating the basis for the investigation of this combination in vivo.

Indexed as

1,2-DipalmitoylphosphatidylcholineA549 CellsAnimalsCarbonCell DeathCell ProliferationGlutathioneHumansMiceMicrogliaMitochondriaNanoparticlesOxidative StressPhosphatidylglycerolsPulmonary AlveoliPulmonary Surfactants1,2-Dipalmitoylphosphatidylcholine1-palmitoyl-2-oleoylglycero-3-phosphoglycerolCarbonGlutathionePhosphatidylglycerolsPulmonary SurfactantsReactive Oxygen Speciesalveolar epithelial cellscarbon nanoparticlesenergy metabolismmicrogliamitochondrial dysfunctionreactive oxygen species (ROS)toxicology

Identifiers

PMID33800016
PMCPMC7962095
OpenAlexW3133857595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.